Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review

2021 ◽  
Author(s):  
Rossella Talotta ◽  
Irene Porrello ◽  
Roberto Restuccia ◽  
Ludovico Magaudda
Keyword(s):  
Physical Activity ◽  
Literature Review ◽  
Idiopathic Inflammatory Myopathies ◽  
Inflammatory Myopathies

Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies

Neurology ◽  
2017 ◽  
Vol 89 (1) ◽  
pp. 101-103 ◽  
Author(s):  
Damien Bachasson ◽  
Océane Landon-Cardinal ◽  
Olivier Benveniste ◽  
Jean-Yves Hogrel ◽  
Yves Allenbach
Keyword(s):  
Physical Activity ◽  
Outcome Measure ◽  
Activity Monitoring ◽  
Idiopathic Inflammatory Myopathies ◽  
Inflammatory Myopathies ◽  
Physical Activity Monitoring

scholarly journals A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies

2019 ◽  
Vol 3 (1) ◽  
Author(s):  
Alexander Oldroyd ◽  
Max A. Little ◽  
William Dixon ◽  
Hector Chinoy
Keyword(s):  
Physical Activity ◽  
Disease Activity ◽  
Disease Duration ◽  
Idiopathic Inflammatory Myopathies ◽  
Activity Levels ◽  
Inflammatory Myopathies ◽  
Activity Data ◽  
Activity Assessment ◽  
Physical Activity Levels ◽  
Disease Activity Assessment

Abstract Background The idiopathic inflammatory myopathies (IIMs) are a group of rare conditions characterised by muscle inflammation (myositis). Accurate disease activity assessment is vital in both clinical and research settings, however, current available methods lack ability to quantify associated variation of physical activity, an important consequence of myositis. This study aims to review studies that have collected accelerometer-derived physical activity data in IIM populations, and to investigate if these studies identified associations between physical and myositis disease activity. Methods A narrative review was conducted to identify original articles that have collected accelerometer-derived physical activity data in IIM populations. The following databases were searched from February 2000 until February 2019: Medline via PubMed, Embase via OVID and Scopus. Results Of the 297 publications screened, eight studies describing accelerometer use in 181 IIM cases were identified. Seven out of the eight studies investigated juvenile dermatomyositis (JDM) populations and only one reported on an adult-onset population. Population sizes, disease duration, accelerometer devices used, body placement sites, and study duration varied between each study. Accelerometer-derived physical activity levels were reduced in IIM cohorts, compared to healthy controls, and studies reported improvement of physical activity levels following exercise programme interventions, thus demonstrating efficacy. Higher levels of accelerometer-derived physical activity measurements were associated with shorter JDM disease duration, current glucocorticoid use and lower serum creatine kinase. However, no clear association between muscle strength and accelerometer-derived physical activity measures was identified. Conclusions The use of accelerometer-derived physical activity in IIM research is in its infancy. Whilst knowledge is currently limited to small studies, the opportunities are promising and future research in this area has the potential to improve disease activity assessment for clinical and research applications.

Biological therapy in idiopathic inflammatory myopathies

2014 ◽  
Vol 155 (1) ◽  
pp. 3-10
Author(s):  
Levente Bodoki ◽  
Melinda Nagy-Vincze ◽  
Zoltán Griger ◽  
Andrea Péter ◽  
Csilla András ◽  
...  
Keyword(s):  
T Cells ◽  
Muscle Weakness ◽  
Biological Therapy ◽  
Therapeutic Options ◽  
Idiopathic Inflammatory Myopathies ◽  
Inflammatory Myopathies ◽  
Progressive Muscle Weakness ◽  
Immune Mediated ◽  
Novel Therapeutic

Idiopathic inflammatory myopathies are systemic, immune-mediated diseases characterized by proximal, symmetrical, progressive muscle weakness. The aim of this work is to give an overview of the biological therapy used in the treatment of idiopathic inflammatory myopathies. The authors also focus on novel results in the therapy directed against the B- and T-cells. They emphasize the importance of new trials in these diseases which may lead to the introduction of novel therapeutic options in these disorders. Orv. Hetil., 2014, 155(1), 3–10.

Sign in / Sign up

Export Citation Format

Share Document